Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China’s Amended Patent Law Could Facilitate Compulsory Licenses Of Pharmaceuticals – Patent Attorneys

This article was originally published in PharmAsia News

Executive Summary

BEIJING - Leaders of China's national legislature are currently reviewing amendments to the patent law that could make it easier to force global pharmaceutical firms to license drugs to Chinese competitors in the event of a public health crisis

You may also be interested in...



China Compulsory Licensing Reg Opens Door For Generics Of Patented Drugs

Taking the lead from India’s recent compulsory license for Bayer’s Nexavar, China passes a compulsory license regulation that could allow generics on patented drugs.

China Compulsory Licensing Reg Opens Door For Generics Of Patented Drugs

Taking the lead from India’s recent compulsory license for Bayer’s Nexavar, China passes a compulsory license regulation that could allow generics on patented drugs.

Thailand Could Seek WTO Solution On Compulsory Licensing, Generic Drugs

SHANGHAI - Multinational drug companies and authorities across developed countries have censured Thailand for using compulsory licensing - a method of forcing pharmaceutical outfits holding patents on innovative medicines to allow other companies to turn out the product

Related Content

UsernamePublicRestriction

Register

SC069393

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel